2brr: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:2brr.gif|left|200px]]<br /><applet load="2brr" size=" | [[Image:2brr.gif|left|200px]]<br /><applet load="2brr" size="350" color="white" frame="true" align="right" spinBox="true" | ||
caption="2brr, resolution 1.95Å" /> | caption="2brr, resolution 1.95Å" /> | ||
'''COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)'''<br /> | '''COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)'''<br /> | ||
| Line 7: | Line 7: | ||
==About this Structure== | ==About this Structure== | ||
2BRR is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with SO4, NH2 and ACY as [http://en.wikipedia.org/wiki/ligands ligands]. Known structural/functional Site: <scene name='pdbsite=AC1:Acy Binding Site For Chain X'>AC1</scene>. Full crystallographic information is available from [http:// | 2BRR is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=SO4:'>SO4</scene>, <scene name='pdbligand=NH2:'>NH2</scene> and <scene name='pdbligand=ACY:'>ACY</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Known structural/functional Site: <scene name='pdbsite=AC1:Acy+Binding+Site+For+Chain+X'>AC1</scene>. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2BRR OCA]. | ||
==Reference== | ==Reference== | ||
| Line 30: | Line 30: | ||
[[Category: transmembrane]] | [[Category: transmembrane]] | ||
''Page seeded by [http:// | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Feb 3 10:27:12 2008'' | ||
Revision as of 11:27, 3 February 2008
|
COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
OverviewOverview
In various western countries, subtype P1.4 of Neisseria meningitidis, serogroup B causes the greatest incidence of meningococcal disease. To, investigate the molecular recognition of this subtype, we crystallised a, peptide (P1HVVVNNKVATH(P11)), corresponding to the subtype P1.4 epitope, sequence of outer membrane protein PorA, in complex with a Fab fragment of, the bactericidal antibody MN20B9.34 directed against this epitope., Structure determination at 1.95 A resolution revealed a unique complex of, one P1.4 antigen peptide bound to two identical Fab fragments. One Fab, recognises the putative epitope residues in a 2:2 type I beta-turn at, residues P5NNKV(P8), whereas the other Fab binds the C-terminal residues, of the peptide that we consider a crystallisation artefact. Interestingly, recognition of the P1.4 epitope peptide is mediated almost exclusively, through the complementarity-determining regions of the heavy chain. We, exploited the observed turn conformation for designing conformationally, restricted cyclic peptides for use as a peptide vaccine. The, conformational stability of the two peptide designs was assessed by, molecular dynamics simulations. Unlike the linear peptide, both cyclic, peptides, conjugated to tetanus toxoid as a carrier protein, elicited, antibody responses in mice that recognised meningococci of subtype, P1.7-2,4. Serum bactericidal assays showed that some, but not all, of the, sera induced with the cyclic peptide conjugates could activate the, complement system with titres that were very high compared to the titres, induced by complete PorA protein in its native conformation administered, in outer membrane vesicles.
About this StructureAbout this Structure
2BRR is a Protein complex structure of sequences from Mus musculus with , and as ligands. Known structural/functional Site: . Full crystallographic information is available from OCA.
ReferenceReference
Crystal structure of an Anti-meningococcal subtype P1.4 PorA antibody provides basis for peptide-vaccine design., Oomen CJ, Hoogerhout P, Kuipers B, Vidarsson G, van Alphen L, Gros P, J Mol Biol. 2005 Sep 2;351(5):1070-80. PMID:16038932
Page seeded by OCA on Sun Feb 3 10:27:12 2008